Aspen Group, Inc. (ASPU) on Q1 2023 Results - Earnings Call Transcript

Operator: Good afternoon. Welcome to Aspen Group's Fiscal Year 2023 First Quarter Earnings Call. Please note that the company's remarks made during this call including answers to questions include forward-looking statements, which are subject to various risks and uncertainties. These statements include anticipated future declines in instructional costs in the second half of fiscal 2023, future tapering of gross margin pressures in late fiscal 2023 and in fiscal 2024, reductions in cash use in operations to position the company to generate positive operating cash flow in the second half of fiscal 2023, our future financing efforts including closing an accounts receivable facility, future savings from reduced marketing, restructuring savings and our liquidity. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. A discussion of risks and uncertainties related to Aspen Group's business is contained in its filings with the Securities and Exchange Commission including the Form 10-K, the fiscal year ended April 30 2022. Form 10-Q, we are filing for the quarter ended July 31, 2022 and in the earnings release issued this afternoon. Aspen Group disclaims any obligation to update any forward-looking statement as a result of future developments. Also I'd like to remind you that during this conference call, the company will discuss EBITDA and adjusted EBITDA, which are non-GAAP financial measures in talking about the company's performance. Reconciliation to the most directly comparable GAAP financial measures are provided in the tables in the earnings release issued by the company today. Please note that the earnings release is available on Aspen Group's website, aspu.com on the IR calendar page under News and Events. There will be a transcript of this conference call available for one-year on the company's website. Please note that the earnings slides are available on Aspen Group's website, aspu.com on the Presentations page under Company Info. Now, I will turn the call over to Michael Mathews, Aspen Group's Chairman and Chief Executive Officer. Michael Mathews: Good afternoon and thank you for joining our call today. Revenue for the fiscal year 2023 first quarter, which is typically our seasonally slowest quarter, was $18.9 million, a modest year-over-year decrease of 3%, which reflects the enrollment stoppage at our BSN pre-licensure campuses in Arizona and the effect of the $1 million sequential reduction of marketing spend in the prior quarter. AU's revenue decreased by $1.3 million or 10% in Q1 fiscal 2023, compared to Q1 fiscal 2022 with the Phoenix pre-licensure program accounting for $800,000 of the decrease, USU's revenue growth of 12% primarily due to demand for the MSN-FNP program helped to offset the AU decrease. The MSN-FNP program remains the strongest program for Aspen Group from a revenue growth perspective. As we discussed in our last earnings call in the fourth quarter of 2022, we temporarily decreased our market spend sequentially by $1 million primarily to ensure sufficient collateral for a surety bond. This quarter's gross margin reflects revenue and marketing spend consistent with third quarter 2022 levels. Another factor affecting the first quarter gross margin was higher instructional costs, which increased by $0.5 million from the prior quarter and $1.2 million year-over-year. Matt, will provide more detail on the costs in his comments. Still as a reminder on our third quarter 2022 conference call, we discussed that instructional costs were increasing due to additional instructors needed to support the ramp of our new pre-licensure campuses and the increase in clinical immersions at additional campuses for the USU MSN-FNP program. We expect instructional costs to begin tailing off in the second half of fiscal 2023 and gross margin pressure to taper as new campus locations mature and the core nursing populations in the Phoenix locations decreased, as we exit fiscal year 2023 and over the course of fiscal year 2024. To offset these cost increases and manage our cash, we recently initiated a restructuring that reduces marketing spend and AGI's total staff by approximately 15%. The staff reductions are focused on G&A areas throughout the company. The restructuring effects are expected to reduce cash used in operations with the effect of these G&A reductions to be reflected in upcoming quarters. With these changes, we believe that we have positioned the company to generate positive operating cash flow in the second half of fiscal 2023. Switching to the first quarter operating metrics. New student enrollments at AU decreased 46% year-over-year and at USU by 34% year-over-year. New student enrollments to AU were primarily impacted by the enrollment stoppage at our Phoenix Pre-Licensure campuses and the overall company reduction in marketing spend by $1 million in Q4 2022 over the prior quarter. AGI's active degree-seeking student body including AU and USU declined 13% year-over-year from 12,048 students from 13,879 students. AU's total active student body decreased by 16% year-over-year to 9,133 from 10,911. On a year-over-year basis, USU's total active student body decreased by 2% to 2,915 from 2,968. Students seeking nursing degrees were 10,394 or 86% of total active students at both universities. Of the students seeking nursing degrees, 8,910 are RNs studying to earn an advanced degree including 6,202 at Aspen University and 2,708 at USU. In contrast, the remaining 1,484 nursing students are enrolled in Aspen University's BSN pre-licensure program in the Phoenix, Austin, Tampa, Nashville and Atlanta metros. The majority of the year-over-year Aspen University nursing student body decrease is a result of the enrollment stoppage in the Phoenix Pre-Licensure program. In conclusion, I want our shareholders to understand that Matt and I are managing Aspen Group's operations with the goal of navigating through this period of declining enrollments due to the Phoenix Pre-Licensure program enrollment stoppage and the related revenue reduction. We have prioritized continued control of our expenses supporting the success of our high LTV business units in particular our MSN-FNP program and our new pre-licensure campuses. As stated on our last earnings call, the company is currently considering various growth and financing alternatives. On August 18, 2022, we entered into an equity distribution agreement that enables us to issue and sell shares of Aspen Group common stock for aggregate gross proceeds of up to $3 million. The facility's primary purpose is to provide additional short-term liquidity, while the expected impact of our restructuring program takes effect. In parallel, we have engaged Lampert Capital Advisors to assist with securing an accounts receivable financing agreement. Until we close in AR financing, the company plans to maintain its current marketing maintenance spending plan. I will now hand the call over to Matt to cover the details of our first quarter financial results. Please go ahead, Matt. Matt LaVay: Thank you, Mike and good afternoon, everyone. In my comments on the quarterly results, I will refer to the first quarter that ended on July 31, 2022. All comparisons are to the prior year's first quarter ended July 31, 2021 unless otherwise stated. I will begin with a review of our financial results for the 2023 fiscal first quarter including some detailed commentary on P&L items and additional commentary on the restructuring program initiated late in Q1. I'll then conclude with comments on our balance sheet. Financial highlights for the quarter are as follows. First, as expected we saw a sequential decrease in our active student body which is consistent with the marketing spend reduction in fiscal Q4 2022. This resulted in a modest quarterly sequential decrease in revenue primarily in our Aspen University online programs. Our active student body decreased from 13,334 in Q4, 2022 to 12,048 in Q1, 2023. Second, we temporarily resumed marketing spend at a level consistent with fiscal Q3 2022 which impacted our gross margin and adjusted EBITDA. This $1 million sequential marketing increase accounts for a significant portion of the adjusted EBITDA loss in the first quarter. Third, continued cost controls further reduced G&A costs versus prior year's first quarter and the sequential prior quarter. Now on to the details. Total revenue was $18.9 million versus $19.4 million in the year ago quarter or a decrease of 3%. This decrease is attributed to the fiscal Q4, 2022 sequential decrease in marketing spend and the stop of enrollments in our Phoenix Pre-Licensure locations. Gross profit and gross margin were $8.2 million and 43% respectively versus $10.4 million and 54% respectively for the year ago quarter. The year-over-year gross margin decline is a function of lower revenue and increased instructional costs and services. Instructional costs for the first quarter were $5.7 million or 30% of revenue up from $4.5 million or 23% of revenue in the year ago quarter. The increase in instructional costs as a percentage of revenue was primarily due to the inflationary impact on faculty compensation and the need for more instructors in our pre-licensure program which is the result of more students entering the core curriculum. The core curriculum requires an increase in the ratio of instructors to students, especially as students enter the clinical portion of the program. The core student population is growing in our Phoenix locations as a result of the progression of double cohorts and in our other new locations as students move into the core portion of the program for the first time. Additionally higher USU immersion related instructional costs were incurred in the quarter due to the growth in the MSN-FNP program. Total marketing and promotional costs for the first quarter were $4.5 million or 24% of total revenue up from $4.1 million or 21% of revenue. The increase of marketing as a percentage of revenue results from the planned increase in marketing spend across all programs to levels consistent with fiscal Q3 2022. The quarter's general and administrative costs were $10.5 million or 56% of total revenue compared to $10.9 million or 56% of total revenue. The quarterly decrease in G&A spend is due to cost controls designed to reduce G&A spend across all functions particularly corporate AGI. Total net loss was $3.7 million or $0.15 per basic and diluted share compared to a net loss of $871,000 or $0.03 per basic and diluted share in the prior year quarter. From a unit perspective, Aspen University's net loss for the quarter was $209,000 compared with net income of $2.3 million. USU's net income was $1.4 million versus $1.3 million. Finally, AGI incurred a net loss of $4.9 million compared to a loss of $4.5 million. The increase in the AGI net loss is due to a full quarter of interest expense. Consolidated EBITDA for the quarter was a loss of $2.2 million as compared to positive EBITDA of $92,000 in the prior year period. First quarter EBITDA period-over-period for each of the three units was as follows. Aspen University generated $549,000 compared to $3.1 million. USU generated $1.5 million compared to $1.3 million. AGI had an EBITDA loss of $4.2 million compared to an EBITDA loss of $4.4 million. The decline in AU EBITDA is attributed to lower revenue associated with the decreased fiscal Q4 2022 marketing spend and the stop of enrollments in our Phoenix Pre-Licensure locations and increased instructional costs associated with our pre-licensure program. Consolidated adjusted EBITDA was a loss of $1.2 million compared to positive adjusted EBITDA of $506,000 in the prior year quarter. From a unit perspective, Aspen University generated adjusted EBITDA of $826,000 compared to adjusted EBITDA of $3 million. Aspen University's adjusted EBITDA margin was 7% as compared to 22%. USU generated adjusted EBITDA of $1.7 million compared to $1.5 million. USU's adjusted EBITDA margin was steady at 24% for both the current and prior year quarter. Finally, AGI corporate incurred an adjusted EBITDA loss of $3.7 million compared to an adjusted EBITDA loss of $3.9 million. As Mike mentioned, we implemented a restructuring plan late in the first quarter of fiscal 2023, which will result in significant cash benefits for the company starting in the second quarter of fiscal 2023 and continuing for the remainder of the fiscal year. They are two key components of the plan. First, in the second quarter we scaled back marketing ad spend to maintenance spend levels of $150,000 per quarter which will result in savings of $3.6 million in Q2 and $3.8 million in each of Q3 and Q4. The savings estimates are based on a normalized marketing ad spend run rate of $4.2 million per quarter. Second, the plan resulted in the elimination of approximately 70 positions, mostly within our G&A functions at Aspen University and AGI. As a result, additional restructuring savings of $750,000 in Q2 and $1.1 million in each of Q3 and Q4 are expected. Total spend reductions will be $4.4 million in Q2 and $4.9 million in each of Q3 and Q4. In summary, these are significant spend reductions which we believe will position the company to generate positive operating cash flows in the second half of fiscal 2023. Moving on to the balance sheet. As of July 31, 2022, our unrestricted cash and cash equivalents were $2.4 million and restricted cash was $6.4 million. As of April 30, 2022, our unrestricted cash and cash equivalents were $6.5 million and restricted cash was $6.4 million. Cash used in operations for the quarter was $3.6 million; $2.2 million of the cash used in operations is attributed to our EBITDA loss. The remaining use of operating cash is primarily attributed to an increase in short-term and long-term accounts receivable related to our monthly payment plans. We also had CapEx spend during the quarter of $500,000. As Mike mentioned, the company entered into an equity distribution agreement that enables us to issue and sell Aspen Group common stock shares for aggregate gross proceeds of up to $3 million. The agreement's primary purpose is to provide additional short-term liquidity as needed ahead of the realization of the benefits we expect from our restructuring program. Finally, we engaged Lampert Capital Advisors to assist with securing an AR financing agreement, although, we are at an early stage and cannot predict if we will achieve our goal of securing financing. With respect to our share count the weighted average number of common basic shares outstanding at the end of the quarter was 25,202,278 versus 25,070,072 in the year ago quarter. At this time, we are not providing guidance. If we close and execute an AR financing agreement, we will update our business plan for the remainder of fiscal 2023. In the meantime, we will manage our expenses with an eye on generating positive operating cash flows in the second half of fiscal 2023. That concludes our prepared remarks. I will now turn the call back to the operator for questions. Operator, please open the call for Q&A. Operator: Thank you. And at this time, we will be conducting a question-and-answer session. And our first question comes from the line of Eric Martinuzzi with Lake Street. Please proceed with your questions. Eric Martinuzzi: Yes. I want to get into the cost reductions. But, first, I wanted to step back and look at the scenarios for the Pre-Licensure BSN in Arizona in 2023. I understand the scores have been improving there in Arizona, but still not at a level that would get you a green light for 2023. So how are you thinking about the Pre-Licensure BSN program for 2023? Michael Mathews: Yes. Good afternoon, Eric, this is Mike. I'll take the second question and I'll give Matt the first question about the restructuring detail. So we're in conversations with the Arizona Board of Nursing. And clearly, the Board of Nursing has various options that range from lifting the stay and initiating the revocation to electing to continue to stay for an additional period of time until achievement of the required 80% pass rate is achieved. So at this point, we don't have a final determination, but we're in discussions. And as we get to our next quarter, we'll probably have more information to provide in that area. Eric Martinuzzi: Okay. And then the restructuring, obviously, you've got G&A as well as a reduction in the spend. Taking back to the number of heads that were eliminated and then the -- compare the prior normalized marketing spend rate with the current? Michael Mathews: Yes. So the number of heads that were eliminated was approximately $70 million. Those heads are in the G&A organization throughout the company. Specifically, there is a concentration in the AU portion of the business and then on the IT side as well. So, the idea was, okay, if we're taking marketing spend down a significant amount, we can gain efficiencies with -- related to that decrease in marketing spend. And then on the IT side the idea is, let's save as much cash as we can while preserving our ability to grow in features. So that's -- those are the thoughts. Eric Martinuzzi: All right. And then the question regarding what was normalized marketing spend if? Michael Mathews: Go ahead. Matt LaVay: Yes. The normalized marketing spend was about $4.2 million. That's what we're basing the decreases from. So just to repeat, the savings are $3.6 million in Q2 and $3.8 million in each of Q3 and Q4. So what's left is that maintenance level needed to kind of keep our marketing engine prime as well as keep some basic infrastructure in place. Eric Martinuzzi: All right. And then, I know you're not giving guidance but given that lower level of -- as you put it a maintenance level spend rate and somewhere at looking at a revenue decline. Do you have any sense of the sequential step down that we can anticipate? Is it going to impact both colleges, both universities, both USU and Aspen U, is it just Aspen U? Michael Mathews: It's -- the marketing spend is spread throughout the organization with the cut that deep you're going to impact both USU and AU. Like we said, we're not giving guidance, but I mean we've given you kind of the high-level way to think about it. So, naturally when there's a decrease in marketing spend, there's a decrease in enrollments, which has an impact on revenue. You saw that this quarter. But, the other side of this is we are doing all of this to generate a healthy bottom line with positive cash flow, right? So, there's a divergence in kind of what happens on the top line and the bottom line. So you'll expect to see that while we are in this -- the mode that we've talked about. Eric Martinuzzi: Got it. And then did you sell any shares under the $3 million ATM? Michael Mathews: Yes, just a de minimis amount. Eric Martinuzzi: Okay. Thank you for taking my questions. Michael Mathews: Thanks, Eric. Operator: And our next question comes from the line of Raj Sharma with B. Riley. Please proceed with your question. Raj Sharma: Hi. Thank you for taking the questions. I want to follow on with the last speaker. What is this -- what is the high level of thinking in terms of the impact on revenue? So every dollar you reduced in marketing spend, how should we think about -- every dollar reduced in marketing spend reduces revenues by the following. Yes, you're reducing the cash flow but that's also – are you pulling from the future of course. And can you give us some color on that or understanding of how to actually understand the impact on revenues? Matt LaVay: Sure. And obviously, you guys are aware of the material decrease in revenues in our Phoenix Pre-Licensure location. So that will continue to show itself as this next year continues. I guess probably the best way to thinking about it is back of the envelope we are currently projecting approximately a 5% reduction in our aggregate student body quarterly. While we're in this maintenance spend mode. And of course, once we obtain an AR facility then we can go back to a more significant spend rate. But for the time being, I would project around a 5% decrease in student body, which the revenues would be probably follow that somewhat. And yes, so that's probably a good way of looking at it. Raj Sharma: Okay. Thank you. And then the – and the same way – so the marketing spend reduces by $3.6 million Q2, $3.8 million, $3.8 million in Q4. The G&A savings of I think you said $4.4 million, $4.9 million, $4.9 million – those are in addition? Matt LaVay: Right. So the G&A savings are $750,000 in Q2. And then in each of Q3 and Q4, it's $1.1 million. And those are based on those headcount reductions that we just talked about. Raj Sharma: Right. So $750000. And so together combined the impact is $4.4 million, $4.9 million, $4.9 million is that right? Matt LaVay: You're correct. Raj Sharma: Okay. Thank you. And then the enrollment, the enrollment, could you give some color on enrollment and how do we sort of see that in the next few quarters? USU was down because of – pre-licensure was down largely because of Phoenix and did enrollment increase in the other – and can you talk about the enrollment in the other ones? And then what happened with USU, USU enrollment decreased significantly and that is your big driver of growth? Can you help us understand? Matt LaVay: Yes. So again, the reason why we had a decrease in enrollments in each of our units is primarily a result of us spending $1 million less from – in Q4, right versus the previous Q3. So this is kind of an expected result for us given the significantly decrease of spend in Q4. I think again, if you're modeling the results in coming quarters I would expect us to have a modest decrease in enrollments sequentially versus the quarter that just ended. Raj Sharma: Right. Is that mid-single digits? Is that low double-digits is… Matt LaVay: What do you mean, sequentially or year-over-year? Raj Sharma: Yes, sequentially is like what sort of level of a decrease in enrollment is that? Matt LaVay: Yes it's going to probably be similar to the revenue it should be mid-single digits. Raj Sharma: -- : Matt LaVay: Well, so -- so to answer to your question, yes when we -- when and if we are able to secure an AR facility, we would then increase our marketing spend. We have yet to develop that plan. It will be based on the level of the financing that we're able to secure. So -- but yes, the idea is we would get out of the maintenance mode, and get back into more of a growth mode from there. As far as the process, it's a multi-step process. So, I'd say we're still kind of at the beginning stages. There's a marketing stage and then there's a diligence stage, and then there's kind of a closing stage. So we're still in that first phase of the process. Because we're early on it's really difficult to say, how long it's going to take to close. And as you guys know, we've had some false starts with this before. So we're not going to get very specific about that time line, but we're in that first step and we continue to march along the process. Q – Raj Sharma: Got it. Okay Thank you. I’ll take the questions offline. Matt LaVay: Thanks, Raj. Q – Raj Sharma: Yes. Thank you. Operator: Our next question comes from the line of Jeremy Hamblin with Craig-Hallum Capital Group. Please proceed with your -- Jack Cole : Hi, Thanks for taking our questions. This is Jack Cole on for Jeremy. I wanted to touch on the increase in instructional costs. You guys noted seeing the effects of wage inflation, having to hire more instructors. Are you guys having difficulty hiring and retaining instructors at these higher wages? And kind of related, how do you think about the overall effects on enrollment as nurses are probably going to be able to earn higher wages with their current education levels. Michael Mathews: Yes. This is Mike Mathews. I'll answer the second question, first. So we've not seen a decrease in demand thus far in terms of, nurses looking to achieve advanced degrees and we certainly haven't seen any trouble as it relates to pre-licensure -- do you want to go ahead and repeat the first question again? I apologize. Jack Cole: Yes. Just if you wanted to expand a little bit more on the instructional increase in instructional costs? Michael Mathews: Yes, there's a couple of different factors that are going on, which we've kind of talked about previously. The first is, in our Phoenix operation about a year ago we began implementing double cohorts. And when you have these double cohorts of course, you have essentially doubled the instructional cost per cohort. So that's the one major reason why. The other reason of course, is the increase of student body over the past year at USU particularly with our FNP program and the weekend immersions that requires of course faculty for that. So those are the two major factors for the increase. And to answer your other part of your question, no, we haven't had any difficulty with hiring faculty necessary to handle our business. Jack Cole: Awesome. Thank you. And then a follow-up question a little different. How is your Atlanta campus tracking so far? Like, what could we see what kind of the ramp rate is so far and if the enrollment is tracking more in line with say the Nashville campus or the Tampa campus? Michael Mathews: Yes. No. I mean, Atlanta is tracking sort of between the highest level, that we've ever seen which is Phoenix Metro versus the Austin Metro. So those are the top two metros in history enrollment-wise. And Atlanta is tracking similar to I'd say Austin at this point. So it's going quite well. Jack Cole: Okay. Thanks for the color. That's all I have. Thank you. Michael Mathews: Thank you. Operator: And our next question comes from the line of Michael Grondahl with Northland Securities. Please proceed with your question. Michael Grondahl: Yeah. Two questions guys. Michael, any thoughts, when Austin, Tampa, Nashville and Atlanta can reach breakeven, on a cash flow basis, any kind of updated projections there? Michael Mathews: Yeah. I mean, I think we've often said publicly that, we need to have revenues of -- on a run rate of approximately $1.5 million in order to breakeven. And Austin is tracking to that soon. The other locations you're looking at fiscal 2024 and 2025 respectively, depending on the maturity of the location. Michael Grondahl: Got it. And I mean put it this way, are you committed to all of those locations, or as you went through this restructuring, I don't know where any of those locations kind of on the map, or are they still part of the plan? Michael Mathews: Yeah. We haven't made any business decisions to remove ourselves from a given market or what's called a, teach-out at this point. As we've often said Tampa has been our most difficult market to-date. And so thus far what we've done is just chosen to shift the marketing spend to higher-levels in our three best markets -- oh, sorry two best markets which is Austin and Atlanta and we've decreased spend somewhat in Nashville and significantly in Tampa. Michael Grondahl: Got it. And then, you had kind of said earlier demand from nurses, remains robust. I'm trying to reconcile that robust demand. It seems like you're losing a little bit of market share. Do you think the overall market and enrollment has softened a little bit, or are you guys just losing a little bit of share? Michael Mathews: Well, yes, I don't -- I wouldn't necessarily conclude that we're losing market share. I think we've now -- in our fiscal Q4 we dropped our spend rate by $1 million, right? And then, we did bring it up again in Q1 and now we're back down to maintenance spend again. So, we've been kind of lumpy in terms of our spend rate as well as the leads that we're driving and therefore enrollment. So I think it's more a function of us, deciding that for the short-term we needed to shift our business plan and focus on generating cash. We've been in business now for over 10 years and we burned cash throughout through this wonderful growth model. And I think we're making a clear statement to all of our shareholders today that we made the moves necessary to restructure the company and to ensure that we don't burn cash on a go-forward basis. And frankly, I've heard from all of our major shareholders that said, Mike, this is the time to do it. And so we made the moves. And this is our plan. Michael Grondahl: Got it. Good. Well, I think sort of the restructuring the reset it makes a lot of sense and good luck in the back half of the year. Michael Mathews: Thanks Mike. Operator: And we have reached the end of the question-and-answer session. I will now turn the call back over to Michael Mathews, for closing remarks. End of Q&A: Michael Mathews: Thank you again for, participating in today's call everyone. We look forward to speaking with you again on our next earnings call, in December. Thank you. Operator: And this concludes today's conference. And you may disconnect your line at this time. Thank you for your participation.
ASPU Ratings Summary
ASPU Quant Ranking
Related Analysis

Aspen Aerogels, Inc. (NYSE:ASPU) Showcases Impressive Financial Performance

  • Aspen Aerogels reported record quarterly revenues of $117.8 million, a 25% increase from the previous quarter and a 145% rise year-over-year.
  • The company's net income reached $16.8 million with Adjusted EBITDA at $28.9 million for the quarter, indicating strong profitability.
  • Aspen Aerogels has raised its revenue and profitability outlook for 2024, reflecting confidence in its business strategy and market position.

Aspen Aerogels, Inc. (NYSE:ASPU), a company specializing in the production of thermal barriers, has recently made headlines with its impressive financial performance. The company, known for its PyroThin product, has seen a significant surge in its stock price following the announcement of its quarterly results. This surge is attributed to the company's revenue more than doubling for the quarter, a testament to its strong operational performance and the increasing demand for its products.

The financial results for the second quarter of 2024 were particularly noteworthy, with Aspen Aerogels reporting record quarterly revenues of $117.8 million. This represents a 25% increase from the previous quarter and a staggering 145% rise year-over-year. Such growth is not only a sign of the company's robust sales strategies but also reflects the broader market's growing interest in sustainable and electrification solutions. Furthermore, the company's profitability has seen a significant boost, with net income reaching $16.8 million and Adjusted EBITDA standing at $28.9 million for the quarter.

In response to these strong financial results, Aspen Aerogels has raised its revenue and profitability outlook for 2024 for the second consecutive quarter. This optimistic adjustment underscores the company's confidence in its business strategy and its ability to maintain a leadership position in the market. The focus on sustainability and electrification solutions is particularly relevant in today's market, aligning with global trends towards greener technologies.

Moreover, Aspen Aerogels' strategic shift from reliance on the oil industry to focusing on the electric vehicle (EV) thermal barriers market is a significant move. Despite the short-term risks associated with high capital expenditures, this pivot positions Aspen Aerogels well for long-term growth. The company's ability to adapt to market demands and invest in promising sectors is a key factor in its current and future success.

The positive outlook is further supported by Northland Securities setting a price target of $3 for ASPU. This endorsement from a financial institution adds an extra layer of credibility to Aspen Aerogels' growth prospects. Investors and market watchers will undoubtedly keep a close eye on the company as it continues to navigate the evolving landscape of sustainable and electrification solutions.